Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2015


Microarray Technology

17 Mar 2015 - 18 Mar 2015 - Berlin, Germany



Bookmark and Share


Building on the successful history of this event, SELECTBIO is pleased to present the 9th annual Microarray Technology conference.

During this conference, the wide range of cutting edge research being conducted using microarray technologies will be discussed. You will gain an insight into the latest developments in clinical uses of microarrays, including pre-implantation diagnosis, pre- & post-natal chromosomal analysis, and the clinical utility of gene expression signatures. You will also hear from leading international speakers about novel technology developments being carried out in this field.

Attending this event will provide you with excellent opportunities for networking with like-minded peers, helping you to find solutions and build collaborations.
Agenda Topics:
-    Basic Research on Microarraying
-    Carbohydrate Arrays
-    Clinical Untility of Gene Expression Signatures
-    DNA Arrays
-    DNA Microarrays vs Next-Generation Sequencing
-    In-situ Production of Protein Arrays
-    Microarray Analysis for Preimplantation Diagnostics
-    Novel Technology Developments & New Directions
-    Pre- & Post-natal Chromosomal Microarray Analysis
-    Protein Arrays in Clinical Practice
-    RNA Analysis


Keynote Speakers:
Denise Batista, Assistant Professor, Johns Hopkins University School Of Medicine
Carl Borrebaeck, Professor and Deputy Vice Chancellor, Lund University
Bertrand Jordan, Emeritus Research Director, Counsellor, CoreBio-PACA, CNRS
Rastislav Levicky, Associate Professor, NYU Polytechnic School of Engineering

The conference will be co-located with Biodetection & Biosensors, Point-of-Care Diagnostics and Lab-on-a-Chip. Registered delegates will have unrestricted access to all co-located meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees.


#AMTECH2105



Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!